Cummings James F. 4

What Happened
James F. Cummings, Chief Medical Officer of Vaxart, had 7,965 shares withheld by the company to satisfy income tax withholding obligations related to the net settlement of restricted stock units (RSUs) that vested on February 2, 2026. The withholding was executed at $0.61 per share for a total value of $4,847. This was a tax-withholding/net settlement transaction (code F), not an open-market sale.

Key Details

• Transaction date: February 2, 2026; Filing date: February 5, 2026 (Form 4 accession 0001437749-26-003255).
• Price per share: $0.61; Shares withheld/disposed: 7,965; Total value: $4,847.
• Transaction code: F (shares withheld to satisfy tax obligations on vested RSUs).
• Footnote F1: Shares were withheld by the issuer to satisfy income tax withholding for RSUs vested as of Feb 2, 2026.
• Footnote F2: The filing notes 75,618 shares were acquired under the Vaxart 2022 Employee Stock Purchase Plan (ESPP).
• Shares owned after the transaction: not specified in the provided excerpt.

Context
This was a routine tax-withholding/net settlement of vested RSUs (company retained shares to cover taxes), not an executive selling shares on the open market. Such withholdings are standard and generally do not signal a change in insider sentiment the way open-market purchases or sales might.